New Therapies of Liver Diseases
| New Therapies of Liver Diseases |
| Autore | Toniutto Pierluigi |
| Pubbl/distr/stampa | Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022 |
| Descrizione fisica | 1 online resource (236 p.) |
| Soggetto topico | Public health and preventive medicine |
| Soggetto non controllato |
acute-on-chronic liver failure
acute-on-chronic liver failure (ACLF) alcoholic hepatitis alpha-fetoprotein ammonia anti-mineralocorticoids antivirals ascites autoantibodies bleeding cholangiocarcinoma cirrhosis cirrhotic ascites clinical trials colorectal cancer metastases decompensated cirrhosis decompensation effective hypovolemia Farnesoid X Receptor (FXR) agonist functional cure furosemide HBV HDV hepatocellular carcinoma human albumin humoral response immunosuppressant immunotherapy infection liver cancer liver injury liver transplantation liver transplantation (LT) loop diuretics Milan criteria n/a non-selective beta-blockers Pan-Peroxisome Proliferator-Activated Receptor (PPAR) agonists pharmacology portal hypertension portal-systemic shunt primary biliary cholangitis primary biliary cholangitis (PBC) primary sclerosing cholangitis (PSC) real-world rifaximin SARS-CoV-2 second line therapy solid organ transplantation statins survival survival rate systemic treatment targeted therapy TIPS tolvaptan treatment response unresectable hepatocellular carcinoma ursodeoxycholic acid ursodeoxycholic acid (UDCA) vaccination vaptans varices vigilance |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910566457403321 |
Toniutto Pierluigi
|
||
| Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022 | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Targeting the Microbiome for Disease Diagnosis and Therapy : New Frontiers for Personalized Medicine
| Targeting the Microbiome for Disease Diagnosis and Therapy : New Frontiers for Personalized Medicine |
| Autore | Laterza Lucrezia |
| Pubbl/distr/stampa | Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022 |
| Descrizione fisica | 1 electronic resource (280 p.) |
| Soggetto topico | Medicine |
| Soggetto non controllato |
Graves-Basedow's diseases
Hashimoto's thyroiditis autoimmunity gut microbiota irritable bowel syndrome microbiota microbiome food components nutrients hematopoietic stem cell transplantation fecal microbiota transplantation aGvHD antibiotic-resistant bacteria cystic fibrosis rabbits intestinal dysbiosis feces microbiome beta-blocker hemodialysis next-generation sequencing propensity score matching methods violin plots random sampling analytical reproducibility fecal matter transplantation data disease subtypes personalized medicine maltodextrin dip test gallstone disease 16S rDNA gene diversity blood biochemical characteristics mesothelioma 16S RNA sequencing species probiotics and gut disease probiotics and acute diverticulitis probiotics and diverticular disease probiotics mechanism of action IgA Nephropathy rifaximin α1KI-CD89Tg mice children intermittent hypoxemia obstructive sleep apnea tonsil weight status oral microbiota rheumatology diseases biomarkers artificial intelligence machine learning rheumatoid arthritis Sjogren's syndrome systemic lupus erythematosus endometrial cancer endometrial microbiome gut microbiome dysbiosis estrogen metabolism estrobolome inflammation antitumour treatment prebiotics probiotics schizophrenia depression anxiety functional genes thymoma genera driver mutation cardiovascular diseases critically ill intestinal permeability recurrent cystitis |
| ISBN | 3-0365-5611-7 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Altri titoli varianti | Targeting the Microbiome for Disease Diagnosis and Therapy |
| Record Nr. | UNINA-9910637781403321 |
Laterza Lucrezia
|
||
| Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022 | ||
| Lo trovi qui: Univ. Federico II | ||
| ||